GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTI BioPharma Corp (FRA:CEPS) » Definitions » Net Interest Income (for Banks)

CTI BioPharma (FRA:CEPS) Net Interest Income (for Banks)


View and export this data going back to 2007. Start your Free Trial

What is CTI BioPharma Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


CTI BioPharma (FRA:CEPS) Business Description

Industry
Traded in Other Exchanges
N/A
Address
3101 Western Avenue, Suite 800, Seattle, WA, USA, 98121
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.